Tetra Pak, Hamlet Pharma and Linnane Pharma have signed a Letter of Intent regarding the development of consumer products
Hamlet and Tetra Pak wish to explore the possibilities to include into food products the active complex (The-A-complex) formed by bovine alpha-lactalbumin and oleic acid (formerly named BAMLET).The objective is to allow Tetra Pak´s customers or other producers of products to include The-A-complex as an ingredient, enabling potential future claims on benefits generated by the active complex. The processing technology and solutions will be sourced from Tetra Pak, the patent rights from Hamlet Pharma and the background scientific and small scale manufacturing know-how from Linnane Pharma,